New Hope for the Addiction-and-Trauma Combo

New Hope for the Addiction-and-Trauma Combo

Have you ever wondered why some people seem to get stuck in a cycle of self-destruction, no matter how much they want to change? Why, despite the devastating consequences – losing jobs, destroying relationships, facing financial ruin, or even ending up unhoused – the pull of the substance or behavior remains stronger than the desire to stop?

In my practice, this is one of the most heartbreaking and complex issues I see. Addiction is often the missing piece that keeps people trapped in their trauma, and trauma is frequently the unseen engine driving the addiction. Let’s take a look at the powerful connection between the two, why traditional approaches sometimes fail, and what the latest research tells us about finally breaking free.

The Chicken or the Egg: Trauma and Addiction

This brings us to a significant debate in clinical practice: Should we treat the trauma first, or the addiction first?

Historically, many therapists and treatment centers operated on a sequential model. They required a client to be completely abstinent from substances before they would even touch the trauma work. The belief was that a person could not effectively process traumatic memories while actively using, and that trauma work might trigger a relapse.

However, this approach often creates a catch-22. If the trauma is the very thing driving the addiction, refusing to treat the trauma until the person is sober is like refusing to treat a patient’s infection until their fever goes down.

Today, the gold standard is moving toward integrated treatment. This means addressing both the trauma and the substance use disorder concurrently, often with a multidisciplinary team. Research shows that integrated treatments, particularly those that are trauma-focused, are highly effective in reducing both PTSD symptoms and substance use [6].

The Adverse Childhood Experiences (ACEs) study, one of the largest investigations into childhood abuse and neglect, found a staggering correlation. For each additional ACE score a person has, their risk of early initiation of substance use increases by two to four times [1]. Individuals with an ACE score of five or higher are seven to ten times more likely to report illicit drug use and addiction [1].

When we look at people currently in treatment for substance use disorders, the numbers are even more telling. Studies show that up to 75% of women and 50% of men in substance abuse treatment have a history of trauma [2].

As Dr. Gabor Maté, a leading expert on addiction, profoundly states:

“Not all addictions are rooted in abuse or trauma, but I do believe they nearly all can be traced to painful experience. A hurt is at the centre of all addictive behaviours. It is present in the gambler, the Internet addict, the compulsive shopper and the workaholic.” [3]

Addiction, in this light, is not a moral failing or a lack of willpower. It is a desperate, maladaptive attempt to soothe an unbearable internal pain. It is a survival strategy that has turned deadly.

The Devastating Ripple Effects

The tragedy of addiction is that the very thing a person uses to escape their pain eventually creates exponentially more of it. The ripple effects are devastating and far-reaching.

Addiction is a major driver of houselessness, with studies indicating that over two-thirds of the unhoused population report substance use as a primary factor in their loss of housing [4]. It ravages physical health, leading to cardiovascular disease, liver failure, severe dental issues, and a high risk of fatal overdose.

But perhaps the most profound damage is relational. Families with a parent struggling with a substance use disorder are often characterized by secrecy, conflict, and emotional chaos [5]. This toxic environment has a detrimental impact on child development, putting the children of addicted parents at a significantly higher risk of developing their own emotional, behavioral, and substance use problems later in life [5].

This creates a vicious cycle of shame. The individual feels deep shame about their addiction and the harm it causes, which in turn fuels the need to numb that shame with more substance use. Breaking this shame spiral is one of the most difficult, yet essential, parts of recovery.

The Internal Family Systems (IFS) Perspective: Managers, Exiles, and Firefighters

To understand why breaking this cycle is so hard, it helps to look at it through the lens of Internal Family Systems (IFS) therapy. IFS offers a compassionate, non-shaming way to understand the internal battle of addiction.

According to IFS, our minds are made up of different “parts.” When we experience trauma, vulnerable parts of us take on the burden of that pain and shame. These are called Exiles. Because the pain of the Exiles is too overwhelming to feel, our system develops protective parts to keep them locked away.

There are two main types of protectors:

Managers: These are proactive parts that try to control our lives to prevent the Exiles from being triggered. They often show up as the harsh inner critic, the perfectionist, the people-pleaser, or the part that creates intense anxiety to keep us hyper-vigilant.

Firefighters: When the Managers fail and the pain of an Exile starts to break through, the Firefighters rush in. They are reactive and impulsive. Their only goal is to extinguish the pain immediately, regardless of the collateral damage.

In the context of addiction, the Firefighter is the part that reaches for the drink, the drug, the food, or the gambling app. It does not care about your job, your marriage, or your health in that moment; it only cares about numbing the Exile’s agony.

This creates a brutal polarization cycle. The Firefighter acts out (using the substance). The Manager then steps in with intense shame, self-hatred, and anxiety about the consequences. This harsh criticism from the Manager causes more pain, which triggers the Exile, which forces the Firefighter to act out again to numb the new pain.

To heal, we cannot just try to lock up the Firefighter (the addiction). We have to help the Manager soften its harshness, and ultimately, we have to heal the wounded Exile so the Firefighter no longer has a fire to put out.

Navigating the Levels of Care

Because addiction is so complex, therapy alone is not always enough, especially in the early stages or with severe physical dependency. The American Society of Addiction Medicine (ASAM) outlines a continuum of care that allows individuals to step up or step down based on their needs [7].

Knowing when to refer a client to a higher level of care is a crucial part of trauma therapy. If a client is actively using in a way that threatens their safety or prevents them from engaging in the therapeutic process, a higher level of care is necessary to establish a foundation of stability.

The Role of Group Support: AA and Beyond

Community is a vital component of recovery. Addiction thrives in isolation, and healing happens in connection.

Alcoholics Anonymous (AA) and other 12-step programs have been the cornerstone of peer support for decades. Research indicates that participation in AA is associated with higher rates of abstinence and lower healthcare costs compared to no intervention [8]. The social support, accountability, and structured steps provide a lifeline for millions.

However, the 12-step model is not the only path, and its spiritual emphasis on a “Higher Power” does not resonate with everyone. Fortunately, there are robust, evidence-based alternatives today:

• SMART Recovery: A science-based, secular program focused on cognitive-behavioral tools to build motivation, cope with urges, manage thoughts, and live a balanced life.
• Refuge Recovery / Recovery Dharma: Mindfulness-based approaches rooted in Buddhist principles of meditation, compassion, and community.
• LifeRing: A secular network focused on empowering the individual’s “sober self” through peer support and personal responsibility.

The research suggests that the specific philosophy of the group matters less than the act of finding a supportive community of peers who understand the struggle [8].

Medication-Assisted Treatment (MAT)

One of the most significant advancements in addiction medicine is Medication-Assisted Treatment (MAT). MAT combines FDA-approved medications with counseling and behavioral therapies. It is considered the gold standard for treating opioid use disorder and is highly effective for alcohol use disorder.

For Opioids: Medications like Buprenorphine (Suboxone) and Methadone stabilize brain chemistry, block the euphoric effects of other opioids, and relieve physiological cravings without producing a high. Naltrexone (Vivitrol) blocks opioid receptors entirely. Studies show MAT reduces opioid overdose deaths by more than 50% [9].

For Alcohol: Naltrexone reduces the reward associated with drinking and decreases cravings. Acamprosate helps stabilize the brain’s chemical balance, and Disulfiram (Antabuse) creates a severe physical reaction if alcohol is consumed.

Despite its proven efficacy, MAT still faces stigma, with some arguing it simply replaces one drug with another. However, the medical consensus is clear: MAT saves lives, increases treatment retention, and provides the neurological stability necessary for individuals to engage in the deep psychological work of trauma recovery [10].

The Frontier: GLP-1s and Psychedelic Therapy

The landscape of addiction treatment is rapidly evolving, with two major frontiers showing incredible promise.

First, GLP-1 Receptor Agonists: A New Frontier in Quieting “Drug Noise”
You probably heard of the unexpected potential of GLP-1 receptor agonists to treat addiction. Medications like semaglutide (Ozempic, Wegovy) were originally developed for diabetes and obesity. However, a groundbreaking 2026 study of over 600,000 veterans published in the BMJ found that initiating a GLP-1 medication was associated with a significantly lower risk of developing new substance use disorders across all major drug classes, including alcohol, opioids, and cocaine. Furthermore, for patients with existing addictions, these drugs reduced the rate of severe outcomes like overdoses and suicide attempts. Clinical trials, such as a recent Phase II study published in JAMA Psychiatry, support these observational findings, showing that semaglutide significantly reduced heavy drinking days and alcohol cravings in adults with alcohol use disorder. Experts like Dr. Anna Lembke from Stanford Medicine explain that GLP-1s appear to quiet “drug noise” by modulating dopamine signaling in the brain’s reward pathways, effectively dampening the compulsive urge to consume .
One of the primary advantages of GLP-1s is that they are not addictive themselves and do not trigger withdrawal, offering a safer pharmacological profile than ketamine. However, the off-label use of these drugs for addiction is not without significant drawbacks. Clinical trials are still in their infancy, and it remains unknown if cravings will aggressively return once the medication is stopped. Additionally, nearly half of users experience gastrointestinal side effects like nausea and vomiting, and there are lingering concerns about whether prolonged dampening of the brain’s reward circuitry might blunt overall motivation and everyday functioning .

Second, Psychedelic-Assisted Therapy is emerging as a powerful tool for both trauma and addiction. Studies using psilocybin for smoking cessation and alcohol use disorder have shown remarkable long-term abstinence rates [12]. MDMA-assisted therapy is currently in late-stage trials for severe PTSD, with researchers exploring its efficacy for co-occurring substance use disorders. These medicines, when used in a controlled clinical setting, appear to act as profound “addiction interrupters,” allowing individuals to process deep trauma and reset rigid neural pathways.

Ketamine-Assisted Psychotherapy: The Paradox of Treating Addiction with an Addictive Substance

The use of ketamine-assisted psychotherapy (KAP) for substance use disorders presents a profound clinical paradox that is currently dividing the medical community. On one hand, recent clinical trials have shown remarkable promise; a landmark Phase II trial demonstrated that combining low-dose ketamine infusions with psychological therapy increased alcohol abstinence rates from roughly 2% to 86% over a six-month period. This success has spurred the launch of the MORE-KARE trial, the largest Phase III study of its kind across eight NHS sites in the UK, aiming to treat 280 adults with severe alcohol use disorder. Proponents argue that ketamine’s ability to rapidly reduce withdrawal symptoms and cravings, particularly for alcohol and cocaine, offers a vital lifeline for patients who have exhausted traditional options. However, this therapeutic optimism is heavily overshadowed by a surging crisis of recreational ketamine abuse and overdose. A 2025 study by King’s College London revealed that illicit ketamine deaths have increased twentyfold since 2014, often involving complex polydrug mixtures. High-profile tragedies, such as the overdose death of actor Matthew Perry, have amplified public and regulatory scrutiny, with experts like Dr. Caroline Copeland warning that ketamine misuse has moved far beyond recreational settings into entrenched dependence. Critics argue that introducing a substance with such high abuse liability and overdose risk into vulnerable populations is inherently dangerous, questioning whether the long-term neurological impacts of repeated ketamine use might ultimately outweigh its rapid anti-craving benefits .

Other emerging treatments, such as Neurofeedback, Transcranial Magnetic Stimulation (TMS), and EMDR 2.0, are also expanding our toolkit, offering new hope for those who have not found success with traditional methods.

The Long Road Home

Addiction is a chronic condition, and relapse is often part of the journey. With relapse rates between 40% and 60%, we must view a return to use not as a moral failure, but as a signal that the treatment plan needs adjustment [13].

Healing from the intertwined wounds of trauma and addiction requires immense courage. It requires us to see the Firefighters not as enemies but as exhausted protectors. It requires a comprehensive approach that addresses the brain’s biology, the wounds of the past, and the present environment.

It is incredibly hard work. But with the right map, the right tools, and a compassionate community, that missing piece can finally be found, and true, lasting freedom is possible.

Life Solutions Counseling
Located at Waypoint Counseling Services
7340 SW Hunziker Street, Suite 102
Tigard, OR 97223

References

[1] National Child Traumatic Stress Network. (n.d.). Adverse Childhood Experiences (ACEs) and Substance Use.
[2] Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). Trauma and Substance Abuse.
[3] Maté, G. (2010). In the Realm of Hungry Ghosts: Close Encounters with Addiction. North Atlantic Books.
[4] Schütz, C. G. (2016). Homelessness and Addiction. Current Treatment Options in Psychiatry.
[5] Lander, L., Howsare, J., & Byrne, M. (2013). The Impact of Substance Use Disorders on Families and Children. Social Work in Public Health.
[6] Torchalla, I., Nosen, L., Rostam, H., & Allen, P. (2012). Integrated treatment programs for individuals with concurrent substance use disorders and trauma. Journal of Substance Abuse Treatment.
[7] American Society of Addiction Medicine (ASAM). (n.d.). ASAM Criteria.
[8] Humphreys, K., Blodgett, J. C., & Wagner, T. H. (2014). Estimating the efficacy of Alcoholics Anonymous. Alcoholism: Clinical and Experimental Research.
[9] Wakeman, S. E., et al. (2020). Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Network Open.
[10] National Institute on Drug Abuse (NIDA). (2021). Medications to Treat Opioid Use Disorder Research Report.
[11] Stanford Medicine. (2025). GLP-1 drugs and addiction: What the science says.
[12] Johnson, M. W., et al. (2014). Pilot study of psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology.
[13] National Institute on Drug Abuse (NIDA). (2020). Drugs, Brains, and Behavior: The Science of Addiction.

References for GLP1 and Ketamine Assisted Psychotherapy

[1] Largest ever trial of ketamine to treat alcohol abuse to launch across eight NHS sites. The Pharmaceutical Journal.
[2] Role of ketamine in the treatment of substance use disorders. ScienceDirect.
[3] Ketamine deaths have increased twentyfold since 2014, with mixing drugs on the rise. King’s College London.
[4] Helpful or harmful? The therapeutic potential of medications with varying degrees of abuse liability in the treatment of substance use disorders. Springer.
[5] GLP-1 drugs hold promise for treating substance addiction. The BMJ.
[6] GLP-1 Drug Semaglutide (Ozempic, Wegovy ) Reduced Heavy Drinking & Craving in Adults with Alcohol Use Disorder. Brain & Behavior Research Foundation.
[7] Five things to know about GLP-1s and addiction. Stanford Medicine.